COVID-19 in 2024: Recommendations and Strategies for Those with CLL and SLL

Description

Much has changed in the four years since COVID-19 was first identified. This includes the virus itself, the recommendations for preventing infection, treatments, reporting, and disease outcomes. While most people have gone about their daily lives not worrying about repeat COVID-19 infections, those who have compromised immune systems still need to be cautious and vigilant with infection control measures and continue to consider the risk.

Join CLL Society and Dr. Shahzad Mustafa as they discuss the status of COVID-19 in the US and what it means for those who are immunocompromised. Additionally, prevention and post-infection isolation recommendations, strategies that can be used to help individuals to safely interact with their community, and an update on the status of pre-exposure prevention using monoclonal antibodies will be discussed.

Advanced Questions

Ask your question in advance of the event by emailing [email protected] by Tuesday, May 14th. Please include “COVID-19 Webinar” in the subject line.

Questions asked in advance are provided to the speaker in preparation for the event. Questions that are applicable to more than one person and succinctly written to have broad interest have a higher chance of being asked by the moderator.

Speakers